By Sarina Isaacs
Vicarious Surgical on Friday said William Kelly is stepping down from his role as chief financial officer.
The Waltham, Mass.-based robotics company said Kelly, who is leaving to pursue other professional opportunities, will stay on until Jan. 2 to help the company transition his responsibilities.
Kelly has been Vicarious Surgical's CFO since January 2021. He was previously CFO at Exosome Diagnostics, a privately held life science company; and CFO at life sciences company Repligen Corp. before that. As CFO at Vicarious, his total compensation in 2023 was $1.6 million.
Vicarious said it has initiated a succession process and will provide updates as appropriate.
Write to Sarina Isaacs at sarina.isaacs@wsj.com
(END) Dow Jones Newswires
December 06, 2024 16:30 ET (21:30 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。